English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduDiscovering antiviral and anticancer drugs will soon be faster and cheaper thanks to new research from Simon Fraser University chemist Robert Britton and his international team. For the past 50 years, scientists have used manmade, synthetic and nucleoside analogues to…
Tag: AIDS/HIV
Provider access to chronic opioid prescribing resources improves guideline adherance
Boston – Results of a new study find that providers participating in an intervention with education and resources to help manage chronic opioid therapy for patients with HIV and chronic pain are more likely to adhere to national chronic opioid…
Study finds benefit in more frequent HIV screenings for young men who have sex with men
A new study has found that HIV screening every three months compared to annually will improve clinical outcomes and be cost-effective among high-risk young men who have sex with men (YMSM) in the United States. The report, led by researchers…
HPV vaccination linked to lower risk of precancerous condition
Vaccination against the human papilloma virus (HPV) reduces the risk of a condition that often leads to cervical cancer, according to an analysis of Danish health registry data. The study, which is published in Acta Obstetricia et Gynecologica Scandinavica ,…
Radboudumc research leads to simplified dosage of HIV medicine for children
The results are integrated in World Health Organization guidelines
PLOS Special Collection: Successful approaches to HIV care
On July 27 2020, the U.S. Department of Health and Human Services’ (HHS) Health Resources and Services Administration (HRSA) launched a Special Collection of manuscripts across the open-access journals PLOS Medicine and PLOS ONE , highlighting Ryan White HIV/AIDS Program’s…
2020 Michelson Prizes support groundbreaking research by young scientists
August 3, 2020 – The Michelson Medical Research Foundation and the Human Vaccines Project are pleased to announce the 2020 Michelson Prizes for Human Immunology and Vaccine Research and support the outstanding research of two young scientists advancing human immunology,…
EMA adopts positive opinion on monthly vaginal ring to reduce HIV risk
IPM’s dapivirine ring could give women in Sub-Saharan Africa first long-acting HIV prevention option; opinion paves way for WHO and National Regulatory Reviews
Kidney transplantation between people with HIV is safe, NIH study finds
Multicenter HOPE Act study expands pool of available kidneys
New study shows how tests of hearing can reveal HIV’s effects on the brain
Even with effective anti-retroviral therapy, patients infected with the Human Immunodeficiency Virus (HIV) sustain central nervous system damage. Whether these problems can be mainly attributed to the disease, its treatments, or the body’s immune responses is still being debated, but…
New study shows how tests of hearing can reveal HIV’s effects on the brain
Even with effective anti-retroviral therapy, patients infected with the Human Immunodeficiency Virus (HIV) sustain central nervous system damage. Whether these problems can be mainly attributed to the disease, its treatments, or the body’s immune responses is still being debated, but…
New drug candidate reawakens sleeping HIV in hopes of functional cure
LA JOLLA, CALIF. – June 23, 2020 – Scientists at Sanford Burnham Prebys Medical Discovery Institute have created a next-generation drug called Ciapavir (SBI-0953294) that is effective at reactivating dormant human immunodeficiency virus (HIV). The research, published in Cell Reports…
Chemist develops potential drug to treat type 2 diabetes without harsh side effects
Syracuse, N.Y. – Syracuse University chemistry professor Dr. Robert P. Doyle has developed a new drug lead to treat type 2 diabetes in millions of patients who are seeking to better control their blood sugar without the common side effects…
New drug candidate reawakens sleeping HIV in hopes of functional cure
LA JOLLA, CALIF. – June 23, 2020 – Scientists at Sanford Burnham Prebys Medical Discovery Institute have created a next-generation drug called Ciapavir (SBI-0953294) that is effective at reactivating dormant human immunodeficiency virus (HIV). The research, published in Cell Reports…
Chemist develops potential drug to treat type 2 diabetes without harsh side effects
Syracuse, N.Y. – Syracuse University chemistry professor Dr. Robert P. Doyle has developed a new drug lead to treat type 2 diabetes in millions of patients who are seeking to better control their blood sugar without the common side effects…
Comparing life expectancy between insured adults with or without HIV
What The Study Did: Researchers estimated the difference in overall life expectancy and years free from major chronic illnesses between individuals with HIV infection with access to care and similar uninfected adults from the same health care system from 2000…
Comparing life expectancy between insured adults with or without HIV
What The Study Did: Researchers estimated the difference in overall life expectancy and years free from major chronic illnesses between individuals with HIV infection with access to care and similar uninfected adults from the same health care system from 2000…
Brain cells can harbor and spread HIV virus to the body
NIH-funded study highlights the importance of addressing the brain in HIV cure strategies
Brain cells can harbor and spread HIV virus to the body
NIH-funded study highlights the importance of addressing the brain in HIV cure strategies
Kashanchi and Liotta studying effect of cannabidiol on exosome release
Fatah Kashanchi, Professor, Laboratory of Molecular Virology, School of Systems Biology, and Lance Liotta, Co-Director, Applied Proteomics and Molecular Medicine, are working to mitigate virally driven HIV pathenogenesis in the central nervous system (CNS). Preliminary data the researchers have gathered…
Study confirms effective, less toxic treatment option for adults with Burkitt lymphoma
Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma In a new study, an alternative treatment regimen that is less toxic than standard dose-intensive chemotherapy was found to be highly effective for adults with Burkitt…
Study confirms effective, less toxic treatment option for adults with Burkitt lymphoma
Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma In a new study, an alternative treatment regimen that is less toxic than standard dose-intensive chemotherapy was found to be highly effective for adults with Burkitt…
Critical window for re-infection with HIV after stem cell transplantation
Some people with HIV need to undergo an allogeneic stem cell transplantation in order to treat different types of blood cancer. Most of the patient’s immune cells are eliminated during these transplantations. Stem cells from a healthy donor are then…
NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
Study enrolling adults with mild to moderate COVID-19 in the United States
Critical window for re-infection with HIV after stem cell transplantation
Some people with HIV need to undergo an allogeneic stem cell transplantation in order to treat different types of blood cancer. Most of the patient’s immune cells are eliminated during these transplantations. Stem cells from a healthy donor are then…
NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
Study enrolling adults with mild to moderate COVID-19 in the United States
Yale researchers discover how HIV hides from treatment
Even after successful antiretroviral therapy, HIV can hide dormant in a tiny number of immune system cells for decades and re-emerge to threaten the life of its host. Now Yale University researchers have discovered a molecular explanation for how the…
Yale researchers discover how HIV hides from treatment
Even after successful antiretroviral therapy, HIV can hide dormant in a tiny number of immune system cells for decades and re-emerge to threaten the life of its host. Now Yale University researchers have discovered a molecular explanation for how the…
New HIV vaccine strategy strengthens, lengthens immunity in primates
Investigators at the Stanford University School of Medicine and several other institutions have shown that a new type of vaccination can substantially enhance and sustain protection from HIV. A paper describing the vaccine, which was given to monkeys, will be…
29 African scientists awarded FLAIR fellowships
Early career African scientists receive up to £300,000 (US$391,500) each to conduct research over 2 years. Scheme supports African researchers to develop into science leaders while establishing independent research careers on the continent. African researchers address today’s global challenges in…
New HIV vaccine combination strategy provides better and more durable protection
ATLANTA – Researchers from the Emory Consortium for Innovative AIDS Research in Nonhuman Primates and their colleagues across North America have shown a new HIV vaccine is better at preventing infection and lasts longer, continuing to protect one year after…
Use of PrEP for HIV prevention among at-risk teens in US
What The Study Did: Nearly 60 articles were reviewed to assess the rate of preexposure prophylaxis (PrEP) use for HIV prevention among at-risk teens in the United States and to provide recommendations for how to improve access to and use…
New HIV vaccine strategy strengthens, lengthens immunity in primates
Investigators at the Stanford University School of Medicine and several other institutions have shown that a new type of vaccination can substantially enhance and sustain protection from HIV. A paper describing the vaccine, which was given to monkeys, will be…
29 African scientists awarded FLAIR fellowships
Early career African scientists receive up to £300,000 (US$391,500) each to conduct research over 2 years. Scheme supports African researchers to develop into science leaders while establishing independent research careers on the continent. African researchers address today’s global challenges in…
New HIV vaccine combination strategy provides better and more durable protection
ATLANTA – Researchers from the Emory Consortium for Innovative AIDS Research in Nonhuman Primates and their colleagues across North America have shown a new HIV vaccine is better at preventing infection and lasts longer, continuing to protect one year after…
Use of PrEP for HIV prevention among at-risk teens in US
What The Study Did: Nearly 60 articles were reviewed to assess the rate of preexposure prophylaxis (PrEP) use for HIV prevention among at-risk teens in the United States and to provide recommendations for how to improve access to and use…
Dual personalities visualized for shape-shifting molecule
Australian and US researchers have made a breakthrough in understanding the structure of a key genetic molecule, called RNA, and revealing for the first time how these changes impact RNA’s function. Publishing in the journal Nature , the research team…
Dual personalities visualized for shape-shifting molecule
Australian and US researchers have made a breakthrough in understanding the structure of a key genetic molecule, called RNA, and revealing for the first time how these changes impact RNA’s function. Publishing in the journal Nature , the research team…
Gladstone scientists identify a new potential reservoir of latent HIV
New study identifies a type of T cells in tissues that preferentially supports latent infection by HIV
Gladstone scientists identify a new potential reservoir of latent HIV
New study identifies a type of T cells in tissues that preferentially supports latent infection by HIV
New study could change what we know about platelets
LEXINGTON, Ky. (April 29, 2020) — University of Kentucky College of Medicine researcher Sidney Whiteheart has been awarded a prestigious Outstanding Investigator Award from the National Heart, Blood and Lung Institute (NHBLI) for his research on how platelets function in…
New study could change what we know about platelets
LEXINGTON, Ky. (April 29, 2020) — University of Kentucky College of Medicine researcher Sidney Whiteheart has been awarded a prestigious Outstanding Investigator Award from the National Heart, Blood and Lung Institute (NHBLI) for his research on how platelets function in…
Sexual risk behavior is reduced with involvement of parents and healthcare providers
Clinic-based ‘families talking together’ is efficacious when put to the test
Can an existing HIV medication slow the spread of COVID-19?
Team of Toronto researchers launches clinical trial to find out if existing HIV medication could prevent COVID-19 infection
Work on rare molecule aims to enhance cell therapy and deliver functional cure for HIV/AIDS
Stanford University chemist Paul Wender and his colleagues are working to improve treatments for cancer, HIV and Alzheimer’s – and they are betting that a drab, weedy marine invertebrate is the means to achieving that end. They have focused on…
University of the Witwatersrand publishes first clinical data on COVID-19 in South Africa
This special issue of the Wits Journal of Clinical Medicine covers a range of aspects of the pandemic, from the clinical, through ethical, to the social dynamics of its impact
Could suicide risk be predicted from a patient’s records?
Computer models flag many patients at risk for suicide attempts, two years ahead of time
Breakthrough discovery in HIV research opens path to new, better therapies
New paper in Science offers ‘paradigm shift in understanding how HIV works’
Women living with HIV prefer long-acting injectable anti-retroviral therapy over daily pill
But concerns remain about access, mistrust, and medical burden
Africa in the path of COVID-19
In a New England Journal of Medicine “Perspective” published today, Wafaa El-Sadr, MD, MPH, global director of ICAP at Columbia University Mailman School of Public Health, and Jessica Justman, MD, ICAP’s senior technical director, and associate professor of epidemiology, urge…